Intravenous iron for heart failure, iron deficiency definitions, and clinical response: the IRONMAN trial

Abstract

This hypothesis-generating analysis suggests that anaemia or TSAT < 20% with ferritin > 100 µg/L might identify patients with heart failure who obtain greater benefit from intravenous iron. This interpretation requires confirmation.